BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33168668)

  • 1. Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo.
    Centeno C; Rojí R; Portela MA; De Santiago A; Cuervo MA; Ramos D; Gandara A; Salgado E; Gagnon B; Sanz A
    BMJ Support Palliat Care; 2022 Jun; 12(2):226-234. PubMed ID: 33168668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
    J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
    Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
    Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
    J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
    Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
    BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with response to methylphenidate in advanced cancer patients.
    Yennurajalingam S; Palmer JL; Chacko R; Bruera E
    Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.
    Moraska AR; Sood A; Dakhil SR; Sloan JA; Barton D; Atherton PJ; Suh JJ; Griffin PC; Johnson DB; Ali A; Silberstein PT; Duane SF; Loprinzi CL
    J Clin Oncol; 2010 Aug; 28(23):3673-9. PubMed ID: 20625123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
    Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
    J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
    Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
    BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
    Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
    J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate as Needed for Fatigue in Patients With Advanced Cancer. A Prospective, Double-Blind, and Placebo-Controlled Study.
    Pedersen L; Lund L; Petersen MA; Sjogren P; Groenvold M
    J Pain Symptom Manage; 2020 Nov; 60(5):992-1002. PubMed ID: 32464260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.
    Mar Fan HG; Clemons M; Xu W; Chemerynsky I; Breunis H; Braganza S; Tannock IF
    Support Care Cancer; 2008 Jun; 16(6):577-83. PubMed ID: 17972110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.
    Atkins C; Fordham R; Clark AB; Stockl A; Jones AP; Wilson AM
    BMJ Open; 2017 Dec; 7(12):e018532. PubMed ID: 29208618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of methylphenidate to relieve fatigue.
    Rojí R; Centeno C
    Curr Opin Support Palliat Care; 2017 Dec; 11(4):299-305. PubMed ID: 28885263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
    Spathis A; Fife K; Blackhall F; Dutton S; Bahadori R; Wharton R; O'Brien M; Stone P; Benepal T; Bates N; Wee B
    J Clin Oncol; 2014 Jun; 32(18):1882-8. PubMed ID: 24778393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
    Escalante CP; Meyers C; Reuben JM; Wang X; Qiao W; Manzullo E; Alvarez RH; Morrow PK; Gonzalez-Angulo AM; Wang XS; Mendoza T; Liu W; Holmes H; Hwang J; Pisters K; Overman M; Cleeland C
    Cancer J; 2014; 20(1):8-14. PubMed ID: 24445757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
    Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
    J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Institute Experience With Methylphenidate and American Ginseng in Cancer-Related Fatigue.
    Chang YD; Smith J; Portman D; Kim R; Oberoi-Jassal R; Rajasekhara S; Davis M
    Am J Hosp Palliat Care; 2018 Jan; 35(1):144-150. PubMed ID: 28299946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
    Lower EE; Fleishman S; Cooper A; Zeldis J; Faleck H; Yu Z; Manning D
    J Pain Symptom Manage; 2009 Nov; 38(5):650-62. PubMed ID: 19896571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.